One of the molecular mechanisms through which cathepsin K contributes to breast cancer progression is by activation of ECM degrading matrix metalloproteinases, which enhances the invasiveness and metastatic capacity of breast cancer cells [97]. This evidence concerns the gene CTSK and breast cancer.